MedTrace Logo

Survival and Reproductive Outcomes of Malignant Ovarian Germ Cell Tumors

NCT05905289 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2024-02-09

No results posted yet for this study

Summary

Malignant ovarian germ cell tumor patients conducted fertility-sparing surgery and adjuvant chemotherapy in Kasr El-Aini Hospital - Faculty of Medicine - Cairo University from January 2012 to December 2016 will be retrospectively investigated.

Conditions

  • Fertility Issues

Interventions

OTHER

observational study

no intervention as it is an observational study

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Mahmoud Ahmed Abd El Hameed, MD · Kasr Al Ainy Hospital, Faculty of Medicine, Cairo University

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2023-12-11
Completion
2023-12-11

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05905289 on ClinicalTrials.gov